Normalization of Hepatic Homeostasis in the Npc1 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat
Andrew B. Munkacsi(Columbia University Irving Medical Center), Stephen L. Sturley(Columbia University), Henry N. Ginsberg(Columbia University), Stephen J. Bloor(Callaghan Innovation), Kirill Lagutin(Callaghan Innovation), Yiannis A. Ioannou(Icahn School of Medicine at Mount Sinai), Daniel Ory(Washington University in St. Louis), Natalie Hammond(Victoria University of Wellington), Nicole Dahlson(The University of Texas Southwestern Medical Center), Dinindu Senanayake(Victoria University of Wellington), Antonio Hernández‐Ono(Columbia University Irving Medical Center), Remy T. Schneider(Columbia University), Robert A. Maue(Dartmouth College), Joyce J. Repa(The University of Texas Southwestern Medical Center), Katsumi Higaki(Tottori University), Fannie W. Chen(Icahn School of Medicine at Mount Sinai)
Cited by 35
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
|Genes & Development|2000|1.7k